AN ACT CONCERNING PRESCRIPTION DRUG COSTS.
To impose additional disclosure and reporting requirements on pharmacy benefits managers, health carriers, pharmaceutical manufacturers, the Office of Health Strategy and the Insurance Department concerning prescription drug rebates and the cost of prescription drugs.
Introduced by:Insurance and Real Estate Committee
|New today||2-4 days old||5 days & older|
Add Notes to HB-5384
Co-sponsors for Amendment LCO:
|4/9/2018||(LCO)||File Number 317|
|4/9/2018||House Calendar Number 212|
|4/9/2018||Favorable Report, Tabled for the Calendar, House|
|4/9/2018||(LCO)||Reported Out of Legislative Commissioners' Office|
|4/2/2018||(LCO)||Referred to Office of Legislative Research and Office of Fiscal Analysis 04/09/18 10:00 AM|
|3/21/2018||(LCO)||Filed with Legislative Commissioners' Office|
|3/20/2018||(INS)||Joint Favorable Substitute|
|3/2/2018||Public Hearing 03/06|
|3/1/2018||Referred to Joint Committee on Insurance and Real Estate|